The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins - PubMed (original) (raw)
The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins
G A Doyle et al. Nucleic Acids Res. 1998.
Abstract
The half-life of c- myc mRNA is regulated when cells change their growth rates or differentiate. Two regions within c- myc mRNA determine its short half-life. One is in the 3'-untranslated region, the other is in the coding region. A cytoplasmic protein, the coding region determinant-binding protein (CRD-BP), binds in vitro to the c- myc coding region instability determinant. We have proposed that the CRD-BP, when bound to the mRNA, shields the mRNA from endonucleolytic attack and thereby prolongs the mRNA half-life. Here we report the cloning and further characterization of the mouse CRD-BP, a 577 amino acid protein containing four hnRNP K-homology domains, two RNP domains, an RGG RNA-binding domain and nuclear import and export signals. The CRD-BP is closely related to the chicken beta-actin zipcode-binding protein and is similar to three other proteins, one of which is overexpressed in some human cancers. Recombinant mouse CRD-BP binds specifically to c- myc CRD RNA in vitro and reacts with antibody against human CRD-BP. Most of the CRD-BP in the cell is cytoplasmic and co-sediments with ribosomal subunits.
Similar articles
- CRD-BP shields c-myc and MDR-1 RNA from endonucleolytic attack by a mammalian endoribonuclease.
Sparanese D, Lee CH. Sparanese D, et al. Nucleic Acids Res. 2007;35(4):1209-21. doi: 10.1093/nar/gkl1148. Epub 2007 Jan 30. Nucleic Acids Res. 2007. PMID: 17264115 Free PMC article. - Molecular insights into the coding region determinant-binding protein-RNA interaction through site-directed mutagenesis in the heterogeneous nuclear ribonucleoprotein-K-homology domains.
Barnes M, van Rensburg G, Li WM, Mehmood K, Mackedenski S, Chan CM, King DT, Miller AL, Lee CH. Barnes M, et al. J Biol Chem. 2015 Jan 2;290(1):625-39. doi: 10.1074/jbc.M114.614735. Epub 2014 Nov 11. J Biol Chem. 2015. PMID: 25389298 Free PMC article. - CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells.
Ioannidis P, Mahaira LG, Perez SA, Gritzapis AD, Sotiropoulou PA, Kavalakis GJ, Antsaklis AI, Baxevanis CN, Papamichail M. Ioannidis P, et al. J Biol Chem. 2005 May 20;280(20):20086-93. doi: 10.1074/jbc.M410036200. Epub 2005 Mar 14. J Biol Chem. 2005. PMID: 15769738 - A family of IGF-II mRNA binding proteins (IMP) involved in RNA trafficking.
Nielsen FC, Nielsen J, Christiansen J. Nielsen FC, et al. Scand J Clin Lab Invest Suppl. 2001;234:93-9. Scand J Clin Lab Invest Suppl. 2001. PMID: 11713986 Review. - CRD-BP: a c-Myc mRNA stabilizing protein with an oncofetal pattern of expression.
Ioannidis P, Mahaira L, Papadopoulou A, Teixeira MR, Heim S, Andersen JA, Evangelou E, Dafni U, Pandis N, Trangas T. Ioannidis P, et al. Anticancer Res. 2003 May-Jun;23(3A):2179-83. Anticancer Res. 2003. PMID: 12894594 Review.
Cited by
- ZDHHC20-mediated S-palmitoylation of YTHDF3 stabilizes MYC mRNA to promote pancreatic cancer progression.
Zhang H, Sun Y, Wang Z, Huang X, Tang L, Jiang K, Jin X. Zhang H, et al. Nat Commun. 2024 May 31;15(1):4642. doi: 10.1038/s41467-024-49105-3. Nat Commun. 2024. PMID: 38821916 Free PMC article. - Homozygous EPRS1 missense variant causing hypomyelinating leukodystrophy-15 alters variant-distal mRNA m6A site accessibility.
Khan D, Ramachandiran I, Vasu K, China A, Khan K, Cumbo F, Halawani D, Terenzi F, Zin I, Long B, Costain G, Blaser S, Carnevale A, Gogonea V, Dutta R, Blankenberg D, Yoon G, Fox PL. Khan D, et al. Nat Commun. 2024 May 20;15(1):4284. doi: 10.1038/s41467-024-48549-x. Nat Commun. 2024. PMID: 38769304 Free PMC article. - Ginsenoside Rg3 decreases breast cancer stem-like phenotypes through impairing MYC mRNA stability.
Ning JY, Zhang ZH, Zhang J, Liu YM, Li GC, Wang AM, Li Y, Shan X, Wang JH, Zhang X, Zhao Y. Ning JY, et al. Am J Cancer Res. 2024 Feb 15;14(2):601-615. doi: 10.62347/GYXE7741. eCollection 2024. Am J Cancer Res. 2024. PMID: 38455405 Free PMC article. - RNA N6-methyladenosine modification in female reproductive biology and pathophysiology.
Huang E, Chen L. Huang E, et al. Cell Commun Signal. 2023 Mar 9;21(1):53. doi: 10.1186/s12964-023-01078-4. Cell Commun Signal. 2023. PMID: 36894952 Free PMC article. Review. - Inhibition of insulin-like growth factor 2 mRNA-binding protein 1 sensitizes colorectal cancer cells to chemotherapeutics.
Betson N, Hajahmed M, Gebretsadek T, Ndebele K, Ahmad HA, Tchounwou PB, Spiegelman VS, Noubissi FK. Betson N, et al. FASEB Bioadv. 2022 Oct 5;4(12):816-829. doi: 10.1096/fba.2021-00069. eCollection 2022 Dec. FASEB Bioadv. 2022. PMID: 36479210 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases